Type
. Detection of Mycobacterium leprae DNA in skin lesions of leprosy patients by PCR may be affected by amplicon size. Archives of dermatological research. 2007;299(5-6):267-71.
Type
. [Hospitals, leper-houses and holy healers and in medieval Berry]. Histoire des sciences medicales. 2006;40(3):283-92.
Type
. Evaluation of major membrane protein-II as a tool for serodiagnosis of leprosy. FEMS microbiology letters [Internet]. 2007;272(2):202-5. Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1574-6968.2007.00754.x/pdf
Type
. Laryngeal lesion in leprosy and the risk of aspiration. Leprosy review. 2007;78(1):80-1.
Type
. The ML flow test as a point of care test for leprosy control programmes: potential effects on classification of leprosy patients. Leprosy review [Internet]. 2007;78(1):70-9. Available from: https://leprosyreview.org/article/78/1/07-079
Type
. A focus on the issues associated with implementing self-care as an intervention. Leprosy review [Internet]. 2007;78(1):57-64. Available from: https://leprosyreview.org/article/78/1/05-764
Type
. Dermatologist. Treating leprosy. Leprosy review. 2007;78(1):56.
Type
. Role of dermatologists in leprosy elimination and post elimination era. Leprosy review [Internet]. 2007;78(1):54-5. Available from: https://leprosyreview.org/article/78/1/05-455
Type
. Role of dermatologists in leprosy. Leprosy review [Internet]. 2007;78(1):52-3. Available from: https://leprosyreview.org/article/78/1/05-253
Type
. Role of dermatologists in leprosy elimination and in the post-elimination era. Leprosy review [Internet]. 2007;78(1):50-1. Available from: https://leprosyreview.org/article/78/1/05-051